Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jan 23, 2024
Date Accepted: Feb 18, 2025

The final, peer-reviewed published version of this preprint can be found here:

Insights Into How mHealth Applications Could Be Introduced Into Standard Hypertension Care in Germany: Qualitative Study With German Cardiologists and General Practitioners

May S, Seifert F, Bruch D, Heinze M, Spethmann S, Muehlensiepen F

Insights Into How mHealth Applications Could Be Introduced Into Standard Hypertension Care in Germany: Qualitative Study With German Cardiologists and General Practitioners

JMIR Mhealth Uhealth 2025;13:e56666

DOI: 10.2196/56666

PMID: 40153776

PMCID: 11992499

Insights into how mHealth applications could be introduced into standard hypertension care in Germany: a qualitative study with German cardiologists and general practitioners

  • Susann May; 
  • Frances Seifert; 
  • Dunja Bruch; 
  • Martin Heinze; 
  • Sebastian Spethmann; 
  • Felix Muehlensiepen

ABSTRACT

Background:

mHealth apps can help to improve treatment adherence, facilitate lifestyle changes or optimize blood pressure control in people with hypertension. However, in Germany, the adoption of digital health technologies, such as mHealth apps, by patients and their endorsement by physicians remain limited. The factors driving physicians' willingness to recommend such mHealth apps are not adequately understood at present.

Objective:

The aim of this study is to develop an understanding of how information needs, and acceptance factors are related in order to best integrate mHealth apps into daily routines.

Methods:

A total of 24 guided telephone interviews were conducted with physicians of hypertensive patients (14 cardiologists, 10 general practitioners). Potential participants were approached following a heterogeneity sampling. Thematic analysis of the data was completed using MAXQDA software.

Results:

Physicians have different information needs regarding the type and functionality of mHealth apps and their effects and benefits for patients. This need for information influences physicians' willingness to recommend mHealth apps. Various determinants of physicians’ willingness were identified. Acceptance increases with more knowledge, with reliable data quality, with the generation shift, with evidence of effectiveness and with pre-defined areas of application and responsibilities. If the information needs were met, acceptance towards mHealth apps and thus the frequency of recommendations would also increase.

Conclusions:

The successful adoption of mHealth apps in the management of hypertension could be significantly enhanced through focused dissemination of knowledge regarding the variety and efficacy of hypertension apps available to patients. Employing a range of knowledge transfer strategies is crucial to facilitate the enduring integration of these apps into daily healthcare practices, ensuring their optimal use and maximizing their potential benefits. Clinical Trial: https://drks.de/search/de/trial/DRKS00029761, identifier DRKS00029761.


 Citation

Please cite as:

May S, Seifert F, Bruch D, Heinze M, Spethmann S, Muehlensiepen F

Insights Into How mHealth Applications Could Be Introduced Into Standard Hypertension Care in Germany: Qualitative Study With German Cardiologists and General Practitioners

JMIR Mhealth Uhealth 2025;13:e56666

DOI: 10.2196/56666

PMID: 40153776

PMCID: 11992499

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.